Sánchez-Gómez Francisco J, Cernuda-Morollón Eva, Stamatakis Konstantinos, Pérez-Sala Dolores
Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Cientificas, Madrid, Spain.
Mol Pharmacol. 2004 Nov;66(5):1349-58. doi: 10.1124/mol.104.002824. Epub 2004 Aug 18.
The cyclopentenone prostaglandin and PPARgamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) displays anti-inflammatory effects in several experimental models. Direct modification of protein thiols is arising as an important mechanism of cyclopentenone prostaglandin action. However, little is known about the extent or specificity of this process. Mesangial cells (MC) play a key role in glomerulonephritis. In this work, we have studied the selectivity of protein modification by 15d-PGJ(2) in MC, and the correlation with the modulation of several proinflammatory genes. MC incubation with biotinylated 15d-PGJ(2) results in the labeling of a distinct set of proteins as evidenced by two-dimensional electrophoresis. 15d-PGJ(2) binds to nuclear and cytosolic targets as detected by fluorescence microscopy and subcellular fractionation. The pattern of biotinylated 15d-PGJ(2)-modified polypeptides is readily distinguishable from that of total protein staining or labeling with biotinylated iodoacetamide. 15d-PGJ(2) addition requires the double bond in the cyclopentane ring. 9,10-Dihydro-15d-PGJ(2), a 15d-PGJ(2) analog that shows the same potency as peroxisome proliferator-activated receptor (PPAR) agonist in MC but lacks the cyclopentenone moiety, displays reduced ability to modify proteins and to block 15d-PGJ(2) binding. Micromolar concentrations of 15d-PGJ(2) inhibit cytokine-elicited levels of inducible nitricoxide synthase, cyclooxygenase-2, and intercellular adhesion molecule-1 in MC. In contrast, 9,10-dihydro-15d-PGJ(2) does not reproduce this inhibition. 15d-PGJ(2) effect is not blocked by the PPARgamma antagonist 2-chloro-5-nitro-N-phenylbenzamide (GW9662). Moreover, compounds possessing an alpha,beta-unsaturated carbonyl group, like 2-cyclopenten-1-one and 2-cyclohexen-1-one, reduce pro-inflammatory gene expression. These observations indicate that covalent modification of cellular thiols by 15d-PGJ(2) is a selective process that plays an important role in the inhibition of MC responses to pro-inflammatory stimuli.
环戊烯酮前列腺素及过氧化物酶体增殖物激活受体γ(PPARγ)激动剂15-脱氧-Δ12,14-前列腺素J2(15d-PGJ2)在多种实验模型中显示出抗炎作用。蛋白质硫醇的直接修饰正成为环戊烯酮前列腺素作用的一种重要机制。然而,关于这一过程的程度或特异性却知之甚少。系膜细胞(MC)在肾小球肾炎中起关键作用。在本研究中,我们研究了15d-PGJ2对MC中蛋白质修饰的选择性,以及与几种促炎基因调节的相关性。用生物素化的15d-PGJ2孵育MC,二维电泳结果表明有一组独特的蛋白质被标记。通过荧光显微镜和亚细胞分级分离检测发现,15d-PGJ2与细胞核及胞质靶点结合。生物素化的15d-PGJ2修饰多肽的模式与总蛋白染色或生物素化碘乙酰胺标记的模式很容易区分。添加15d-PGJ2需要环戊烷环中的双键。9,1,0-二氢-15d-PGJ2是一种15d-PGJ2类似物,在MC中显示出与过氧化物酶体增殖物激活受体(PPAR)激动剂相同的效力,但缺乏环戊烯酮部分,其修饰蛋白质和阻断15d-PGJ2结合的能力降低。微摩尔浓度的15d-PGJ2可抑制细胞因子诱导的MC中诱导型一氧化氮合酶、环氧化酶-2和细胞间黏附分子-1的水平。相比之下,9,10-二氢-15d-PGJ2不能重现这种抑制作用。15d-PGJ2的作用不能被PPARγ拮抗剂2-氯-5-硝基-N-苯基苯甲酰胺(GW9662)阻断。此外,具有α,β-不饱和羰基的化合物,如2-环戊烯-1-酮和环己烯-1-酮,可降低促炎基因表达。这些观察结果表明,15d-PGJ2对细胞硫醇的共价修饰是一个选择性过程,在抑制MC对促炎刺激的反应中起重要作用。